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Abstract
 
CD1d-restricted autoreactive natural killer (NK)T cells have been reported to regulate a range
of disease conditions, including type I diabetes and immune rejection of cancer, through the
secretion of either T helper (Th)2 or Th1 cytokines. However, mechanisms underlying Th2
versus Th1 cytokine secretion by these cells are not well understood. Since most healthy sub-
jects express 
 
 
 
1 NKT cell per 1,000 peripheral blood lymphocytes (PBLs), we devised a new
method based on the combined used of T cell receptor (TCR)-specific reagents 
 
 
 
-galactosyl-
ceramide (
 
 
 
GalCer) loaded CD1d-tetramers and anti-V
 
 
 
24 monoclonal antibody, to specifi-
cally identify and characterize these rare cells in fresh PBLs. We report here that CD4
 
 
 
 and
CD4
 
 
 
CD8
 
  
 
(double negative [DN]) NKT cell subsets represent functionally distinct lineages
with marked differences in their profile of cytokine secretion and pattern of expression of
chemokine receptors, integrins, and NK receptors. CD4
 
 
 
 NKT cells were the exclusive pro-
ducers of interleukin (IL)-4 and IL-13 upon primary stimulation, whereas DN NKT cells had a
strict Th1 profile and prominently expressed several NK lineage receptors. These findings may
explain how NKT cells could promote Th2 responses in some conditions and Th1 in others,
and should be taken into consideration for intervention in relevant diseases.
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Introduction
 
NKT cells are a conserved subpopulation of 
 
  
 
 T cells,
which are restricted by the antigen-presenting molecule
CD1d, and appear to regulate several disease processes
ranging from tumor rejection to autoimmune diseases (for
a review, see references 1 and 2). They express a con-
served canonical TCR (V
 
 
 
14J
 
 
 
18-V
 
 
 
8 in mouse and
V
 
 
 
24J
 
 
 
18-V
 
 
 
11 in human) that is thought to recognize a
self-antigen mimicked by the glycolipid 
 
 
 
GalCer. Since
NKT cells are present at high frequency in various mouse
tissues and in human liver, they seem to participate in the
innate, rather than the adaptive arm of the immune re-
sponse and resemble other innate lymphocytes such as B-1
B cells and 
 
  
 
 T cells which express canonical antigen re-
ceptors responding to cell stress and tissue damage (3, 4).
Importantly, CD1d is mainly expressed on dendritic cells
(DCs), macrophage, and B cells, implying that NKT cells
primarily interact with APCs rather than tissue cells.
The secretion of Th1 and Th2 cytokines by NKT cells is
thought to underlie their regulatory properties. For exam-
ple, they can suppress type I diabetes in NOD mouse
through the secretion of IL-4 and IL-10 (5, 6) and their de-
fects in both NOD mice and humans with IDDM may
contribute to pathogenesis (7, 8). Conversely, they naturally
suppress methylcholantrene-induced carcinogenesis through
 
IFN-
 
 
 
 (9). In another report, secretion of the Th2 cytokine
IL-13 was found to inhibit the immune rejection of a tu-
mor graft (10). Collectively, these findings suggest that reg-
ulated expression of Th1 or Th2 cytokines by NKT cells,
rather than mere changes in its frequency (7, 11, 12), might
control the outcome of some disease conditions.
 
How could the Th1- versus Th2-promoting functions of
NKT cells be selectively recruited? It has been suggested that
 
altered 
 
 
 
GalCer ligands with shorter sphingosine chain could
selectively activate Th2 functions (13), whereas NK1.1 sig-
naling could favor Th1 response (14). However, the possibil-
ity that subsets of NKT cells might specialize in Th1 versus
Th2 functions has not been thoroughly investigated.
 
One obstacle to the identification of NKT cell subsets has
been that, until recently, NKT cells could not be unambigu-
 
ously identified. The generation of CD1d-
 
 
 
GalCer tetramers
specific for both mouse and human canonical TCR makes it
possible to identify NKT cells based on their specificity rather
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than their phenotype (15–17). CD1d tetramers have already
revealed several important findings, including a subset of
CD1d-restricted murine NKT cells that do not express the
NK1.1 marker and differ from the NK1.1
 
 
 
 cells with respect
to their pattern of integrins (15). However, detailed examina-
tion of human NKT cells has not been performed.
An additional challenge to the study of fresh human
PBLs is the very low frequency of canonical NKT cells, of-
ten well below common background level staining of
0.1%. Here, we have used a combination of CD1d-
 
 
 
Gal-
Cer tetramers and anti-V
 
 
 
24 mAb, which specifically
identifies the canonical NKT cells even at the very low fre-
quencies found in human PBLs, to investigate human
NKT cell subsets. We have dissected the phenotype of
these cells into CD4 and double negative (DN) popula-
tions, and found that they systematically differed in many
functionally relevant ways with respect to Th cytokine
profile, pattern of chemokine receptors, and integrin ex-
pression, and array of NK receptors displayed on the cell
surface. These findings suggest that human CD4 and DN
V
 
 
 
24 NKT cells represent functionally separate lineages
that may promote different Th responses.
 
Materials and Methods
 
Antibodies.
 
Fluorochrome or biotin conjugates of antibodies
against V
 
 
 
24, V
 
 
 
11, CD4, CD25, CD28, CD56, CD94, NKG2A
(Beckman Coulter); CCR1, CCR2, CXCR6 (R&D Systems);
CCR4, CCR5, CCR6, CCR7, CXCR3, CXCR4, CD45RA,
CD45RB, CD45RO, CD49a, CD49b, CD49d, CD49e, CD49f,
CD69, CD152, CD154, CD158a, CD158b, CD161, IL-4, IL-13,
TNF-
 
 
 
, and IFN-
 
 
 
 (BD Biosciences) were used.
 
Flow Cytometric Analysis.
 
PBLs were obtained from whole
blood of healthy donors by centrifugation over Ficoll (Amersham
Pharmacia Biotech) gradient. Cells were then washed three times
with PBS before surface staining. Staining with CD1d-
 
 
 
GalCer tet-
ramers was as follows. Cells were incubated with 1 
 
 
 
g/ml unlabeled
streptavidin (Pierce Chemical Co.) for 15 min at room temperature,
followed by incubation with CD1d-
 
 
 
GC tetramers (15) for 1 h at
room temperature. Other mAbs such as CD4 and V
 
 
 
24 were then
added for a further 30 min incubation on ice. Cells were then
washed with staining buffer (PBS, 0.1% BSA; Sigma-Aldrich) and
0.01% sodium azide (Sigma-Aldrich) and analyzed by flow cytome-
try using FACSort™ and CELLQuest™ software (Becton Dickin-
son). For studies involving CD152 or intracellular cytokines, cells
were first stained with tetramers, then permeabilized with Cytofix/
Cytoperm™ (BD Biosciences), and washed with Perm/Wash™
buffer (BD Biosciences). Appropriate mAbs were then added for 30
min before two further washes with Perm/Wash™ buffer.
 
Stimulation of Cytokine Production.
 
PBLs were cultured for 12 h
at a concentration of 5 
 
 
 
 10
 
6
 
 cells per milliliter in RPMI 1640
supplemented with 10% FCS (Biofluids) in the presence of 1 ng/
ml of phorbol-myristate-acetate (PMA), 1 
 
 
 
M of ionomycin, and
5 
 
 
 
g/ml of Brefeldin A (all from Sigma-Aldrich).
 
Results
 
Specific Identification of Human NKT Cells Using CD1d-
 
 
 
GalCer Tetramers and Anti-V
 
 
 
24 mAbs.
 
To accurately iden-
tify potential subsets of the rare circulating human NKT
 
cells above background staining levels, we combined the
use of two TCR-specific reagents, a mAb to V
 
 
 
24 and
CD1d-
 
 
 
GalCer tetramers. We found that, although
CD1d-
 
 
 
GalCer tetramer staining is completely inhibited
by prior incubation with the anti-V
 
 
 
24 mAb (15), the re-
verse reaction order allowed significant binding of anti-
V
 
 
 
24, presumably because the tetramers require contigu-
ous clusters of TCR to bind, leaving a significant amount
of unbound TCR available for bright V
 
 
 
24 staining. Fig. 1
A shows that the frequency of V
 
 
 
24/CD1d-
 
 
 
GalCer dou-
ble positive canonical NKT cells in the fresh PBLs of
healthy volunteers is between 0.01 and 0.1%. Importantly,
tetramer staining alone invariably included 
 
 
 
0.01–0.05%
nonV
 
 
 
24 cells, which are noncanonical cells that presum-
ably reflect background staining (Fig. 1 B, top left quad-
rants in left dot plots). Thus, whereas the population de-
fined by conventional tetramer staining alone included a
significant proportion of nonNKT cells in most healthy in-
dividuals, especially in those with low NKT cell frequency,
the double staining combination allowed complete speci-
ficity. This is shown by the 100% expression of V
 
 
 
11
among the V
 
 
 
24/CD1d-
 
 
 
GalCer double-positive cells
(Fig. 1 B, right dot plots). In the sample expressing 0.01%
NKT cells, 100 out of 100 gated cells were V
 
 
 
11
 
 
 
, indi-
cating that this technique specifically identified all of the
100 canonical NKT cells present among 1 million PBL.
 
CD4 and DN Subsets Have Different Cytokine Secretion
Profiles.
 
A fraction of V
 
 
 
24 NKT cells expresses CD4
while the remaining is CD8
 
 
 
-negative and is called DN.
While the proportion of the CD4 and DN varied consider-
ably between individuals, on average, they were roughly
equal (50%) in a group of 10 healthy individuals (Fig. 1 B,
and data not shown). Surprisingly, despite reports that the
corresponding mouse subsets exhibit similar cytokine secre-
tion properties (18), systematic differences were found in
10/10 individual human subjects examined. Thus, upon ex
vivo stimulation with the combination of ionomycin and
Figure 1. Identification of human NKT cells. (A) NKT cells present
among the PBL of 10 healthy adults were enumerated after double stain-
ing with CD1d- GC tetramers followed by anti-V 24. Each dot repre-
sents an individual sample. (B) PBL from individuals expressing high (top
panels) or low (bottom panels) NKT cell numbers were stained with
CD1d- GC tetramers followed by anti-V 24, -V 11, and CD4 mAb.
Two-color combinations are displayed to illustrate correlations between
different subsets. Right panels are gated on V 24/CD1d- GC double-
positive cells. 
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PMA, nearly all the IL-4 and IL-13 stained by intracellular
FACS
 
®
 
 were present in CD4
 
 
 
 cells (Fig. 2). In contrast,
both the CD4 and DN subsets produced abundant Th1 cy-
tokines such as TNF-
 
 
 
 and IFN-
 
 
 
. Interestingly, the IL-
2R
 
 
 
 chain (CD25) was exclusively expressed by CD4
 
 
 
 cells
(10–80% positive), indicating that CD4
 
 
 
 NKT cells repre-
sent a fraction of human CD4
 
 
 
CD25
 
 
 
 regulatory cells.
 
CD4 and DN Subsets Have Different Patterns of Chemokine
Receptors and Integrins.
 
When we examined a broad range
of chemokine receptors and integrins (Fig. 3), significant
differences were systematically found between CD4 and
DN cells with respect to the expression of CCR5, CCR6,
CXCR6, and CD49a. Other chemokine receptors and in-
 
tegrins were similarly expressed in both subsets, includ-
ing CCR1 and CCR2 (
 
 
 
2%), CXCR3 and CXCR4
(2–100%), CCR4 (100%), and CCR7 (
 
 
 
2%) (data not
shown). Likewise, both CD4 and DN NKT cells expressed
abundant CD49d, CD49e, and CD49f but limited CD49b
(data not shown).
NK lineage receptors are mainly expressed by the DN
subset. One of the hallmarks of mouse NKT cells is the ex-
pression of receptors of the NK lineage, which regulate
cellular activation by fine tuning TCR signaling. Using a
battery of NK receptor-specific reagents, we have found
systematic differences between CD4 and DN NKT cells
(Fig. 4). Thus, CD161, which costimulates TCR activation
Figure 2. Different cytokine and cytokine
receptor profiles of CD4 and DN NKT
cells. Fresh PBLs were rested or stimulated
with PMA/ionomycin for 12 h before stain-
ing with CD1d- GalCer tetramers followed
by permeabilization and staining with mAbs
to V 24, CD4, and cytokines or cytokine
receptors. (A) FACS® dot plots from a rep-
resentative individual are shown, after gating
on CD1d- GalCer/V 24 double-positive
cells. Numbers in the quadrants indicate
percentages of cells within the CD4 or DN
subsets (top and bottom quadrants, respec-
tively). (B) Summary of cytokine expression
from 10 individual subjects. White circles
represent the CD4 subset while black circles
represent the DN subset. Significant differ-
ences (Student’s paired t test) were found for
IL-4 (P    0.01) and IL-13 (P     0.01).
Staining of CD25 (IL-2R ) was performed
without membrane permeabilization.
Figure 3. Different chemokine receptor and integrin pattern of CD4
and DN NKT subsets. The CD1d- GalCer/V 24 double-positive PBLs
were gated for analysis of CD4 and chemokine receptors or CD49a. (A)
FACS® dot plots of a representative PBL sample. Numbers in the quad-
rants indicate percentages of cells within the CD4 or DN subsets (top and
bottom quadrants, respectively). (B) Summary of chemokine receptor and
CD49a expression from 10 individual subjects. White circles represent
the CD4 subset, while black circles represent the DN subset. Significant
differences (Student’s paired t test) were found for CCR5 (P   0.05),
CCR6 (P   0.01), CXCR6 (P   0.05), and CD49a (P   0.05).
Figure 4. Different patterns of NK receptor expression by CD4 and
DN NKT cells. The CD1d- GalCer/V 24 double-positive PBLs were
gated for analysis of CD4 and 2B4, CD94, NKG2A, or CD161. (A)
FACS® dot plots of a representative PBL sample. Numbers in the quad-
rants indicate percentages of cells within the CD4 or DN subsets (top and
bottom quadrants, respectively). (B) Summary of NK receptor expression
from 10 individual subjects. White circles represent the CD4 subset,
while black circles represent the DN subset. Significant differences (Stu-
dent’s paired t test) were found for 2B4 (P   0.001), CD94 (P   0.05),
NKG2A (P   0.05), and CD161 (P   0.01). 
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(14), was expressed at a higher density and at greater fre-
quency by DN NKT cells. Likewise, 2B4, CD94, and
NKG2A were nearly exclusively expressed by DN NKT
cells. On the other hand, CD56 was highly expressed by
both subsets, whereas the KIR CD158a and CD158b were
generally not expressed (data not shown).
 
Other Surface Receptors Expressed by Fresh NKT Cell Sub-
sets.
 
There were no systematic differences for costimula-
tory receptors such as CD28, which was generally ex-
pressed by most CD4 and DN NKT cells. In contrast,
cytotoxic T lymphocyte antigen 4 and CD40L were ex-
pressed by very small fractions of NKT cells (data not
shown). Most CD4 and DN NKT cells expressed
CD45RO and CD45RB, but not CD45RA (data not
shown). CD69 was equally expressed by 
 
 
 
50% of both
CD4 and DN NKT cells.
 
Discussion
 
By combining the use of TCR-specific reagents such as
CD1d-
 
 
 
GalCer tetramer and anti-V
 
 
 
24 mAb, we could
specifically identify all canonical V
 
 
 
24 NKT cells, even at
the very low frequencies found among the PBLs of most
healthy individuals. Indeed, we demonstrated that the dou-
ble staining method allowed correct and specific identification
of every NKT cell among 1 million PBLs, a 100–1,000-
fold improvement over conventional tetramer tracking
methods, which is likely to apply to other T cell subsets.
Using this methodology, we were able to characterize
functionally distinct subsets and show that they segregate
with the CD4 and DN subsets of NKT cells.
While both CD4 and DN NKT cells could produce
Th1 cytokines, the release of Th2 cytokines such as IL-4
and IL-13 was the exclusive property of CD4 T cells. CD4
and DN NKT cells also exhibited systematic differences in
their pattern of chemokine receptors and integrins, suggest-
ing different migratory properties. Finally, the expression of
several NK receptors was restricted to the DN lineage. Al-
together, these findings reveal that the CD4 and DN sub-
sets represent distinct lineages with markedly different
functional properties.
The restricted production of Th2 cytokines by fresh
CD4 NKT cells apparently conflicts with a prior study
showing that DN NKT cell clones derived from healthy
individuals produced Th2 cytokines, whereas those of
IDDM patients were Th1 (7). It is possible that the culture
system modified their primary cytokine profile, as repeated
stimulation was reported to downmodulate Th1 cytokines
and upregulate Th2 (19). Our study suggests that a reexam-
ination of the functional status of NKT cell subsets in
IDDM patients is warranted to verify whether the conclu-
sions derived from the in vitro studies will apply to fresh
NKT cell subsets.
This study of human V
 
 
 
24 NKT cells also points to a
surprising difference between the mouse and the human
system. Indeed, the mouse CD4 and DN NKT cells do not
clearly differ with respect to Th1 versus Th2 cytokine se-
 
cretion or NK receptor expression (18). Further studies are
required to elucidate the mechanisms underlying Th2 ver-
sus Th1 regulation in mouse. It is possible that other subsets
or alternative mechanisms, such as altered glycolipid ligand
(13) or NK receptor signaling (14), could account for the
control of Th function in these conditions.
In conclusion, our study of fresh human V
 
 
 
24 NKT re-
vealed the existence of two functionally distinct lineages of
CD4 and DN cells. These lineages might be differentially
altered or recruited in various disease conditions, providing
a potential mechanism explaining how NKT cells might
promote opposite Th1 or Th2 responses. A detailed under-
standing of this regulation will be critical to design future
strategies to manipulate the immune response through
NKT cell activation.
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